These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30193106)

  • 41. Effects of ALS-associated TANK binding kinase 1 mutations on protein-protein interactions and kinase activity.
    Ye J; Cheung J; Gerbino V; Ahlsén G; Zimanyi C; Hirsh D; Maniatis T
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24517-24526. PubMed ID: 31748271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions.
    Kumar V; Islam A; Hassan MI; Ahmad F
    Biochim Biophys Acta; 2016 Sep; 1862(9):1742-54. PubMed ID: 27318084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
    Iridoy MO; Zubiri I; Zelaya MV; Martinez L; Ausín K; Lachen-Montes M; Santamaría E; Fernandez-Irigoyen J; Jericó I
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Amyotrophic lateral sclerosis and frontotemporal dementia: overlapping characteristics].
    Raaphorst J; Grupstra HF; Linssen WH; van Swieten JC; Schmand B; de Visser M
    Ned Tijdschr Geneeskd; 2010; 154():A631. PubMed ID: 20178658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FTD and ALS: genetic ties that bind.
    Orr HT
    Neuron; 2011 Oct; 72(2):189-90. PubMed ID: 22017980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Weishaupt JH; Hyman T; Dikic I
    Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].
    Lillo P; Matamala JM; Valenzuela D; Verdugo R; Castillo JL; Ibáñez A; Slachevsky A
    Rev Med Chil; 2014 Jul; 142(7):867-79. PubMed ID: 25378006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
    Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
    Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frustration analysis of TBK1 missense mutations reported in ALS/FTD and cancer patients.
    Khatoon F; Kumar V; Anjum F; Shafie A; Adnan M; Hassan MI
    3 Biotech; 2022 Aug; 12(8):174. PubMed ID: 35845111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
    Tomiyama H
    Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of highly specific antibodies for Serine/threonine-protein kinase TBK1 for use in immunoblot, immunoprecipitation and immunofluorescence.
    Alshafie W; Fotouhi M; Shlaifer I; Ayoubi R; Edwards AM; Durcan TM; McPherson PS; Laflamme C
    F1000Res; 2022; 11():977. PubMed ID: 36415206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy.
    Seelen M; Visser AE; Overste DJ; Kim HJ; Palud A; Wong TH; van Swieten JC; Scheltens P; Voermans NC; Baas F; de Jong JM; van der Kooi AJ; de Visser M; Veldink JH; Taylor JP; Van Es MA; van den Berg LH
    Neurobiol Aging; 2014 Aug; 35(8):1956.e9-1956.e11. PubMed ID: 24612671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Commentary: Effects of ALS-associated TANK binding kinase 1 mutations on protein-protein interactions and kinase activity.
    Freischmidt A; Brenner D; Ludolph AC; Andersen PM; Weishaupt JH
    Front Neurosci; 2020; 14():551006. PubMed ID: 33013311
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
    Ji AL; Zhang X; Chen WW; Huang WJ
    J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genetics of Amyotrophic Lateral Sclerosis].
    Czell D
    Praxis (Bern 1994); 2019 Jan; 108(1):37-44. PubMed ID: 30621546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ALS Genes in the Genomic Era and their Implications for FTD.
    Nguyen HP; Van Broeckhoven C; van der Zee J
    Trends Genet; 2018 Jun; 34(6):404-423. PubMed ID: 29605155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of the caudate nucleus head and its networks in sporadic amyotrophic lateral sclerosis-frontotemporal dementia continuum.
    Masuda M; Senda J; Watanabe H; Epifanio B; Tanaka Y; Imai K; Riku Y; Li Y; Nakamura R; Ito M; Ishigaki S; Atsuta N; Koike H; Katsuno M; Hattori N; Naganawa S; Sobue G
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):571-579. PubMed ID: 27684890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia.
    Van Langenhove T; Piguet O; Burrell JR; Leyton C; Foxe D; Abela M; Bartley L; Kim WS; Jary E; Huang Y; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR
    J Alzheimers Dis; 2017; 58(1):163-170. PubMed ID: 28387671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease.
    Synofzik M; Born C; Rominger A; Lummel N; Schöls L; Biskup S; Schüle C; Grasshoff U; Klopstock T; Adamczyk C
    Neurobiol Aging; 2014 May; 35(5):1212.e1-5. PubMed ID: 24300238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.